Literature DB >> 9688951

Characterization of a mitogen-activated protein kinase from Pneumocystis carinii.

C F Thomas1, T J Kottom, E B Leof, A H Limper.   

Abstract

The pathogenic fungus Pneumocystis carinii causes severe pneumonia in patients with impaired immunity, particularly patients with acquired immunodeficiency syndrome. The life cycle of P. carinii is poorly understood, and the inability to continuously culture P. carinii is a major limitation in understanding its cell biology. In fungi homologous to P. carinii, pheromone mating factors signal through a mitogen-activated protein kinase (MAPK) signal transduction cascade, resulting in mitotic cell cycle arrest and entry into a pathway of conjugation, cellular differentiation, and proliferation. Using degenerate PCR and library screening, we have identified a MAPK cDNA in P. carinii that is highly homologous to fungal MAPKs involved in the pheromone mating signal transduction cascade, and we demonstrate MAPK activity in P. carinii lysates with a specific antiserum derived from the translated P. carinii MAPK cDNA sequence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688951     DOI: 10.1152/ajplung.1998.275.1.L193

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Pneumocystis carinii expresses an active Rtt109 histone acetyltransferase.

Authors:  Theodore J Kottom; Junhong Han; Zhiguo Zhang; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-23       Impact factor: 6.914

2.  Pneumocystis carinii cell wall biosynthesis kinase gene CBK1 is an environmentally responsive gene that complements cell wall defects of cbk-deficient yeast.

Authors:  Theodore J Kottom; Andrew H Limper
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

3.  Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast.

Authors:  Theodore J Kottom; Julia R Köhler; Charles F Thomas; Gerald R Fink; Andrew H Limper
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.